Ethylene

Ethylene

SCHEMBL6991302

C=C.CCOC(C)OCC.O=C1CN(CCN2CCN(c3ccc(F)cc3)CC2)S(=O)(=O)c2ccccc21

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
DRD2 P14416 8/20 0.42
HTR1A P08908 6/20 0.42
DRD4 P21917 3/20 0.41
DRD3 P35462 3/20 0.41
DRD5 P21918 2/20 0.41
HTR2A P28223 5/20 0.40
HTR7 P34969 5/20 0.40
HTR6 P50406 5/20 0.40
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
ADRA1D P25100 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
HTR2C P28335 1/20 0.39
SLC6A4 P31645 1/20 0.39
HRH1 P35367 1/20 0.39
OPRK1 P41145 1/20 0.39
HTR5A P47898 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL6998179 0.95 DRD2 (0.47) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6995999 0.95 DRD2 (0.45) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6999262 0.88 DRD2 (0.51) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6995806 0.87 DRD2 (0.45) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6995582 0.86 MEN1 (0.40) DRD2HTR1ADRD4DRD3HTR2A
Ethylene SCHEMBL6994585 0.86 DRD2 (0.54) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6996278 0.86 HTR1A (0.46) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6987484 0.85 DRD2 (0.56) TDP1DRD2HTR1ADRD4DRD3
Ethylene SCHEMBL6994468 0.83 DRD2 (0.41) DRD2HTR1ADRD4DRD3DRD5
Ethylene SCHEMBL6996875 0.83 CACNA1G (0.41) DRD2HTR1ADRD4DRD3DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664251-B2 Serotonin receptor antagonist; treating cardiovascular disorder DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2003-12-16 US disclosed
EP-0686632-B1 BENZOTHIAZINE DERIVATIVE DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-08-06 EP disclosed
US-20030078256-A1 Benzothiazine derivative SUNTORY LIMITED (JP) 2003-04-24 US disclosed
US-6316442-B1 TREATMENT OF HEART DISEASE AND CEREBROVASCULAR DISTURBANCES SUNTORY LIMITED (JP) 2001-11-13 US disclosed
US-6001827-A Benzothiazine derivative SUNTORY LIMITED (JP) 1999-12-14 US disclosed
EP-0686632-A1 BENZOTHIAZINE DERIVATIVE SUNTORY LIMITED (JP) 1995-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078256-A1 Benzothiazine derivative TPH2, ADRB2, TPH1 TDP1 3378/4885DRD2 402/4885HTR1A 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.